Table 4.
Age stratification analysis
Age | Percentage of positivity | |||||
---|---|---|---|---|---|---|
TST | QFT-IT | IP-10 | ||||
HC | HHC | HC | HHC | HC | HHC | |
≤17 years | 1.2# | 37.3 | 2.3# | 50.5 | 2.3# | 62.7* |
18–30 years | 20.5 | 55.8 | 24.1 | 64.7 | 33.3 | 70.6 |
31–45 years | 28.6 | 66.7 | 31.3 | 68.1 | 40.0 | 80.9 |
>45 years | 33.3 | 46.2 | 90* | 89.5* | 93.0* | 84.2* |
The difference between the positivity of tests was calculated using Fisher’s exact test. The cut-off point of 10mm was used for tuberculin skin test.
represents significantly higher when compared to TST.
represents significantly lower compared to subjects >17 years. A p value of <0.05 is considered significant.
QFT-IT - QuantiFERON TB Gold (In-tube),
TST - Tuberculin Skin test
N - Number of subjects
NS - Not significant